Stock

Nasdaq Announces Quarterly Dividend of $0.49 Per Share

Retrieved on: 
Wednesday, October 21, 2020
Financial markets, Dividends, Finance, Shareholders, Corporate finance, Stock market, Nasdaq, Inc., Stock

NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.49 per share on the company's outstanding common stock.

Key Points: 
  • NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.49 per share on the company's outstanding common stock.
  • The dividend is payable on December 18, 2020 to shareholders of record at the close of business on December 4, 2020.
  • Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.
  • To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com .

Kalera AS: Contemplated private placement and listing on Merkur Market

Retrieved on: 
Wednesday, October 21, 2020
Corporate finance, Stock market, Finance, Financial economics, Money, Equity securities, Book building, Oslo Stock Exchange, Stock

The bookbuilding period in the Private Placement will commence today, 21 October 2020 at 09:00 hours CEST and close on 23 October 2020 at 15:00 hours CEST.

Key Points: 
  • The bookbuilding period in the Private Placement will commence today, 21 October 2020 at 09:00 hours CEST and close on 23 October 2020 at 15:00 hours CEST.
  • Kalera has applied for, and will, subject to successful completion of the Private Placement and the necessary approvals from the Oslo Stock Exchange, list the shares of the Company on Merkur Market (the Listing).
  • The first day of trading on Merkur Market is expected to be on or about 28 October 2020.
  • The Company's Board of Directors reserves the right to cancel the Private Placement at any time and for any reason prior to delivery of the New Shares.

PARSLEY ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PE and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, October 21, 2020
Financial economics, Stock market, Corporate finance, Finance, Equity securities, Edible plants, Apioideae, Parsley, Common stock, Security, Stock, Derivative

On October 20, 2020, Parsley announced that it had signed an agreement to be acquired by Pioneer for approximately $4.5 billion.

Key Points: 
  • On October 20, 2020, Parsley announced that it had signed an agreement to be acquired by Pioneer for approximately $4.5 billion.
  • Pursuant to the merger agreement, Parsley stockholders will receive 0.1252 shares of Pioneer common stock for each share of Parsley common stock owned.
  • Bragar Eagel & Squire is concerned that Parsleys board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Lefteris Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

Retrieved on: 
Wednesday, October 21, 2020
Corporate finance, Financial markets, Financial economics, Finance, Equity securities, Stock market, Options, Warrant, Initial public offering, Stock, Pricing

BOSTON, Oct. 20, 2020 /PRNewswire/ -- Lefteris Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.

Key Points: 
  • BOSTON, Oct. 20, 2020 /PRNewswire/ -- Lefteris Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.
  • Each unit consists of one share of the Company's Class A common stock and one-third of one redeemable warrant.
  • Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share.
  • The Company has granted the underwriters a 45-day option to purchase up to 3,000,000 additional units at the initial public offering price to cover over-allotments, if any.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Cleveland BioLabs, Inc. Merger

Retrieved on: 
Tuesday, October 20, 2020
Financial markets, Finance, Money, Cleveland BioLabs, Fiduciary, NASDAQ, Stock

announces that it is investigating Cleveland BioLabs, Inc. (Cleveland) (NASDAQ GS: CBLI ) regarding possible breaches of fiduciary duties and other violations of law related to Clevelands agreement to merge with Cytocom, Inc. (Cytocom).

Key Points: 
  • announces that it is investigating Cleveland BioLabs, Inc. (Cleveland) (NASDAQ GS: CBLI ) regarding possible breaches of fiduciary duties and other violations of law related to Clevelands agreement to merge with Cytocom, Inc. (Cytocom).
  • Under the terms of the agreement, Cleveland will issue a number of shares of Cleveland common stock to shareholders of Cytocom.
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cleveland-biolabs-inc .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .

RiverNorth Opportunities Fund, Inc. Extends Rights Offering

Retrieved on: 
Tuesday, October 20, 2020
Corporate finance, Equity securities, Stock market, Rights issue, Stock, Economy

DENVER, Oct. 20, 2020 /PRNewswire/ --RiverNorth Opportunities Fund, Inc. (NYSE: RIV) (the "Fund") announces that it has extended the expiration date ("Expiration Date") of the Fund's previously announced transferable subscription rights offering (the "Rights Offering") to 5:00 PM Eastern Time on November 6, 2020, unless further extended by the Fund's Board of Directors.

Key Points: 
  • DENVER, Oct. 20, 2020 /PRNewswire/ --RiverNorth Opportunities Fund, Inc. (NYSE: RIV) (the "Fund") announces that it has extended the expiration date ("Expiration Date") of the Fund's previously announced transferable subscription rights offering (the "Rights Offering") to 5:00 PM Eastern Time on November 6, 2020, unless further extended by the Fund's Board of Directors.
  • The extension of the Rights Offering does not require that the holders of transferable subscription rights ("Rights") who have already subscribed to purchase shares under the Rights Offering take any action.
  • Shares of common stock issued pursuant to the Rights Offering will be record date shares for the purposes of the Fund's November 2020 distribution payable.
  • RiverNorth is an investment management firm founded in 2000 that specializes in opportunistic strategies in niche markets where the potential to exploit inefficiencies is greatest.

Eargo, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Tuesday, October 20, 2020
Financial markets, Finance, Stock market, Money, Corporate finance, Stock, NASDAQ, Ticker symbol, BofA Securities

All of the shares of common stock were offered by Eargo.

Key Points: 
  • All of the shares of common stock were offered by Eargo.
  • Eargos common stock began trading on The Nasdaq Global Select Market on October 16, 2020, under the ticker symbol EAR.
  • J.P. Morgan and BofA Securities acted as lead book-running managers and as representatives of the underwriters for the offering.
  • Eargos innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost.

Replimune Announces Proposed Public Offering

Retrieved on: 
Tuesday, October 20, 2020
Finance, Financial economics, Financial markets, Corporate finance, Initial public offering, Stock market, SVB Leerink, Public offering, NASDAQ, Stock, Underwriting

BOSTON, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced a proposed public offering of $125 million of shares of its common stock.

Key Points: 
  • BOSTON, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced a proposed public offering of $125 million of shares of its common stock.
  • In addition, Replimune intends to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of shares of its common stock from Replimune at the public offering price, less the underwriting discounts and commissions.
  • J.P. Morgan Securities LLC and SVB Leerink LLC are acting as joint book-running managers for the proposed offering.
  • The proposed offering is subject to market and other customary closing conditions, and Replimune cannot assure you as to whether or when the proposed offering may be completed.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, October 20, 2020
Financial markets, Stock market, Financial economics, Finance, Initial public offering, Security, Stock, Short, Grant & Eisenhofer, Securities Class Action

Investors have until October 27, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 27, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On or about June 22, 2020, defendants conducted Progenitys IPO.
  • Shortly after the IPO, the price of Progenity stock suffered significant price declines.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Parsley Energy Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Parsley Energy, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PE

Retrieved on: 
Tuesday, October 20, 2020
Legal, Professional services, Financial markets, Financial economics, Articles, Stock market, Corporate finance, Equity securities, Apioideae, Legal entities, Shareholder, Securities fraud, Parsley, Stock

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Parsley Energy, Inc. (NYSE: PE) to Pioneer Natural Resources Company for 0.1252 shares of Pioneer common stock for each share of Parsley common stock is fair to Parsley shareholders.

Key Points: 
  • Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Parsley Energy, Inc. (NYSE: PE) to Pioneer Natural Resources Company for 0.1252 shares of Pioneer common stock for each share of Parsley common stock is fair to Parsley shareholders.
  • On behalf of Parsley shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • If you are a Parsley shareholder and would like to discuss your legal rights and options, please visit Parsley Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] .
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.